Aquestive Therapeutics AQST
NASDAQ AQST
$4.55 +0.11 (+2.48%)
At close: Oct 2, 2026 · 4:00 PM EDT

Aquestive Therapeutics (AQST) Cash & Current Investments (2017 - 2026)

Updated

Aquestive Therapeutics (AQST) recorded Cash & Current Investments of $98.49 million in Q2 2026, up 62.7% from $60.54 million a year earlier but down 11.1% from the prior quarter.

Analysis

Aquestive Therapeutics (AQST) Cash & Current Investments (2017 - 2026) Analysis & Trends

At the end of FY2025, Aquestive Therapeutics reported Cash & Current Investments of $121.17 million, up 69.4% from FY2024.

  • Annual Cash & Current Investments has a five-year compound annual growth rate of 30.7% (FY2020 to FY2025).
  • Across earlier years, Cash & Current Investments came in at $71.55 million in FY2024 (+199.7%), $23.87 million in FY2023 (-12.5%), $27.27 million in FY2022 (-2.7%) and $28.02 million in FY2021 (-11.9%).
  • Quarterly Cash & Current Investments has ranged from $14.74 million in Q1 2022 to $129.06 million in Q3 2025 over the past five years.
  • On a year-over-year basis, Cash & Current Investments has increased for four consecutive quarters, with growth averaging 76.4% over the last eight quarters.
  • Peak year-over-year performance for Cash & Current Investments in the last five years was growth of 300.6% in Q2 2024, against a decline of 48.3% in Q2 2022 at the low end.
  • Per Business Quant, the preceding three quarters came in at $110.73 million (Q1 2026), $121.17 million (Q4 2025) and $129.06 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 20.76 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 6.57 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 7.14 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 9.92 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 4.97 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 3.18 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 11.70 Bn
10 Aquestive Therapeutics 571.08 Mn 111.62 Mn 9.80 Mn 98.49 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 98.49 Mn
Mar 31, 2026 110.73 Mn
Dec 31, 2025 121.17 Mn
Sep 30, 2025 129.06 Mn
Jun 30, 2025 60.54 Mn
Mar 31, 2025 68.66 Mn
Dec 31, 2024 71.55 Mn
Sep 30, 2024 77.89 Mn
Jun 30, 2024 89.87 Mn
Mar 31, 2024 95.20 Mn
Dec 31, 2023 23.87 Mn
Sep 30, 2023 24.92 Mn
Jun 30, 2023 22.44 Mn
Mar 31, 2023 26.88 Mn
Dec 31, 2022 27.27 Mn
Sep 30, 2022 18.65 Mn
Jun 30, 2022 17.70 Mn
Mar 31, 2022 14.74 Mn
Dec 31, 2021 28.02 Mn
Sep 30, 2021 31.16 Mn
API Access

Aquestive Therapeutics Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=AQST&period=max&api_key=YOUR_API_KEY